A first: All respond to gene therapy in a blood cancer study
Share
Tweet
June 4, 2017
CHICAGO (AP) — Doctors are reporting unprecedented success from a new cell and gene therapy for multiple myeloma, a blood cancer that's on the rise. Although it's early and the study is small — 35 people — every patient responded and all but two were in some level of remission within two months.
In a second study of nearly two dozen patients, everyone above a certain dose responded.
Experts at an American Society of Clinical Oncology conference in Chicago, where the results were announced Monday, say it's a first for multiple myeloma and rare for any cancer treatment to have such success.
Chem...
For access to this article please
sign in or
subscribe.
Reader Comments(0)